Literature DB >> 2491230

Using mortality data for profiling hospital quality of care and targeting substandard care.

E L Hannan1.   

Abstract

This paper reviews the utilization of hospital mortality data to (1) provide information for review agents to use in reviewing medical records for quality of care problems and (2) provide information to consumers on the relative quality of care provided by hospitals. First, the Health Care Financing Administration's 1987 mortality study is reviewed by discussing some of its methodological strengths and limitations and by conducting a validation of its results. Next, a recent study by the New York State Department of Health aimed at targeting specific cases for medical record review is discussed. A final section provides recommendations for alterations and extensions of previous research.

Mesh:

Year:  1989        PMID: 2491230

Source DB:  PubMed          Journal:  J Soc Health Syst        ISSN: 1043-1721


  3 in total

1.  Performance of Hospitals When Assessing Disease-Based Mortality Compared With Procedural Mortality for Patients With Acute Myocardial Infarction.

Authors:  Ashwin S Nathan; Qun Xiang; Daniel Wojdyla; Sameed Ahmed M Khatana; Elias J Dayoub; Rishi K Wadhera; Deepak L Bhatt; Daniel M Kolansky; Ajay J Kirtane; Sunil V Rao; Robert W Yeh; Peter W Groeneveld; Tracy Y Wang; Jay Giri
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

2.  The impact of extreme-risk cases on hospitals' risk-adjusted percutaneous coronary intervention mortality ratings.

Authors:  Matthew W Sherwood; J Matthew Brennan; Kalon K Ho; Frederick A Masoudi; John C Messenger; W Douglas Weaver; David Dai; Eric D Peterson
Journal:  JACC Cardiovasc Interv       Date:  2014-12-10       Impact factor: 11.195

3.  Postoperative wound dehiscence after laparotomy: a useful healthcare quality indicator? A cohort study based on Norwegian hospital administrative data.

Authors:  Jon Helgeland; Oliver Tomic; Tonya Moen Hansen; Doris Tove Kristoffersen; Sahar Hassani; Anne Karin Lindahl
Journal:  BMJ Open       Date:  2019-04-03       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.